CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
DiaSorin has received FDA clearance for its Liaison aldosterone immunoassay, which is intended for the quantitative determination of aldosterone in human serum, EDTA plasma, and urine samples.
The test is used primarily for the diagnosis of hypertension.
The addition of the new aldosterone assay to the Liaison analyzer menu, and its combination with the direct renin assay, positions DiaSorin to provide a complete hypertension panel.
DiaSorin, 651-439-9710